Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer

Completed · Phase 2/Phase 3

Conditions studied: Prostate Cancer

In brief

This was an extension study for the study FE200486 CS14 (NCT00116779). Each participant was to be treated until he was discontinued or withdrawn from the study, or a marketing authorization for degarelix had been obtained. The study was terminated when all ongoing participants had been treated for at least 5 years.

Key facts

Study ID

NCT00117286

Run by

Ferring Pharmaceuticals

People needed

57

Starts

2005-03-01

Expected to finish

2009-11-01

Last updated by the study team

2025-12-18

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Has given written consent prior to any study-related activity being performed. A study-related activity is defined as any procedure that would not have been performed during the normal management of the patient.
• Has completed study FE200486 CS14 through visit 22.
• Exclusion Criterion:
• Has been withdrawn from the FE200486 CS14 study.

Where it is running

• Urology Centers of Alabama — Homewood, Alabama, United States
• Advanced Urology Medical Center — Anaheim, California, United States
• West Coast Clinical Research — Tarzana, California, United States
• Western Clinical Research — Torrance, California, United States
• Urology Associate PC' — Denver, Colorado, United States
• South Florida Medical Research — Aventura, Florida, United States
• SW Florida Urological Associates — Fort Myers, Florida, United States
• Northeast Indiana Research, LLC — Fort Wayne, Indiana, United States
• Regional Urology — Shreveport, Louisiana, United States
• Lawrenceville Urology — Lawrenceville, New Jersey, United States
• The Urology Center — Greensboro, North Carolina, United States
• State College Urologic Association — State College, Pennsylvania, United States
• University Urological Research Institute — Providence, Rhode Island, United States
• Urology San Antonio Research — San Antonio, Texas, United States
• University of Vermont, Dept of Surgery — South Burlington, Vermont, United States
• Virginia Urology Center — Richmond, Virginia, United States
• Investigational site — Seattle, Washington, United States
• Can-Med Clinical Research, Inc. — Victoria, British Columbia, Canada
• The Male and Female Health and Research Centers — Barrie, Ontario, Canada
• Brantford Urology Research — Brantford, Ontario, Canada
• Burlington Professional Care — Burlington, Ontario, Canada
• The Female/Male Health Centres — Oakville, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.